Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure - Wohlford, George F; Van Tassell, Benjamin W; Billingsley, Hayley E; Kadariya, Dinesh; Canada, Justin M; Carbone, Salvatore; Mihalick, Virginia L; Bonaventura, Aldo; Vecchié, Alessandra; Chiabrando, Juan Guido; Bressi, Edoardo; Thomas, Georgia; et al. (Journal of cardiovascular pharmacology, 2020)